← back to search

Molly Thomas

Sciensano (Belgium) · US
Area of research
Oncology · Infectious Diseases
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Plant biochemistry and biosynthesis, COVID-19 Clinical Research Studies, and SARS-CoV-2 and COVID-19 Research.
h-index
27
citations
3,952
works
116
NIH funding
primary concept
Medicine
email

Recent publications

Immune responses in checkpoint myocarditis across heart, blood and tumour
Nature 2024cited by 53position: middledoi
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis
Nature Medicine 2024cited by 52position: firstdoi
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients
Cell Reports Medicine 2022cited by 70position: middledoi
Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions
Cell Reports Medicine 2021cited by 309position: middledoi
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
Cell 2021cited by 165position: middledoi
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes
Journal of Clinical Investigation 2021cited by 122position: middledoi
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
Science Immunology 2021cited by 87position: middledoi
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Science 2020cited by 768position: middledoi
Alginate Encapsulant Incorporating CXCL12 Supports Long-Term Allo- and Xenoislet Transplantation Without Systemic Immune Suppression
American Journal of Transplantation 2015cited by 125position: middledoi
Eri1 regulates microRNA homeostasis and mouse lymphocyte development and antiviral function
Blood 2012cited by 71position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2015–2015) · 1 papers (2015–2015)Vigo Heissmeyer · Ludwig-Maximilians-Universität München1 papers (2012–2012)Athanassios Sambanis · Georgia Institute of Technology1 papers (2015–2015)K. Mark Ansel · University of California, San Francisco1 papers (2012–2012)Jian‐Ping Yuan · Wuhan University1 papers (2015–2015)Mark C. Poznansky · Harvard University1 papers (2015–2015)Prescott G. Woodruff · Advanced ENT and Allergy1 papers (2012–2012) · 1 papers (2015–2015)Ben Forbes · King's College London1 papers (2015–2015)Stephanie Duncanson · Georgia Institute of Technology1 papers (2015–2015) · 1 papers (2015–2015)Misha Rajaram · University of California, San Francisco1 papers (2012–2012)James F. Markmann · Center for Systems Biology1 papers (2015–2015)Choli Hartono · Hackensack University Medical Center1 papers (2015–2015)David H. Sachs · Icahn School of Medicine at Mount Sinai1 papers (2015–2015)Sarah Abdul‐Wajid · University of Utah1 papers (2012–2012)Joshua Babiarz · Natera (United States)1 papers (2012–2012)Ji Lei · York University1 papers (2015–2015) · 1 papers (2015–2015)